Endothelial endothelin-1 over-expression using receptor tyrosine kinase tie-1 promoter leads to more severe vascular permeability and blood brain barrier breakdown after transient middle cerebral artery occlusion

Brain Research

Volumn 1266, Issue , 2009, Pages 121-129

  Leung, Justin W C ^a   Chung, Stephen S M ^a   Chung, Sookja K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Blood brain barrier; Endothelial receptor; Ischemia; Stroke

Indexed keywords

AQUAPORIN 4; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; GELATINASE A; IMMUNOGLOBULIN; OCCLUDIN; TIE 1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN EDEMA; BRAIN INFARCTION SIZE; CONTROLLED STUDY; DISEASE SEVERITY; GENE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TIE 1 GENE; UPREGULATION; WATER CONTENT;

ANIMALS; AQUAPORIN 4; BLOOD-BRAIN BARRIER; BRAIN; CAPILLARY PERMEABILITY; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; IMMUNOGLOBULINS; INFARCTION, MIDDLE CEREBRAL ARTERY; MATRIX METALLOPROTEINASE 2; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; NADPH OXIDASE; OXIDATIVE STRESS; PROMOTER REGIONS, GENETIC; PYRROLIDINES; RECEPTOR, ENDOTHELIN A; RECEPTOR, TIE-1; SUPEROXIDES; TYROSINE; WATER;

MUS MUSCULUS;

EID: 63449101376     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.01.070     Document Type: Article

References (31)

1. Abbott N. Astrocyte-endothelial interactions and blood-brain barrier permeability. J. Anat. 200 (2002) 527
2. Badaut J., Lasbennes F., Magistretti P.J., and Regli L. Aquaporins in brain: distribution, physiology, and pathophysiology. J. Cereb. Blood Flow Metab. 22 (2002) 367-378
3. Banes-Berceli A.K., Ogobi S., Tawfik A., Patel B., Shirley A., Pollock D.M., Fulton D., and Marrero M.B. Endothelin-1 activation of JAK2 in vascular smooth muscle cells involves NAD(P)H oxidase-derived reactive oxygen species. Vascul. Pharmacol. 43 (2005) 310-319
4. Barone F.C., Globus M.Y., Price W.J., White R.F., Storer B.L., Feuerstein G.Z., Busto R., and Ohlstein E.H. Endothelin levels increase in rat focal and global ischemia. J. Cereb. Blood Flow. Metab. 14 (1994) 337-342
5. Bian L.G., Zhang T.X., Zhao W.G., Shen J.K., and Yang G.Y. Increased endothelin-1 in the rabbit model of middle cerebral artery occlusion. Neurosci. Lett. 174 (1994) 47-50
6. Callaway J.K., Knight M.J., Watkins D.J., Beart P.M., and Jarrott B. Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats. Stroke 30 (1999) 2704-2712 discussion 2712
7. Chan P.H. Role of oxidants in ischemic brain damage. Stroke 27 (1996) 1124-1129
8. Chuquet J., Benchenane K., Toutain J., MacKenzie E.T., Roussel S., and Touzani O. Selective blockade of endothelin-B receptors exacerbates ischemic brain damage in the rat. Stroke 33 (2002) 3019-3025
9. Dawson D.A., Sugano H., McCarron R.M., Hallenbeck J.M., and Spatz M. Endothelin receptor antagonist preserves microvascular perfusion and reduces ischemic brain damage following permanent focal ischemia. Neurochem. Res. 24 (1999) 1499-1505
10. Dirnagl U., Iadecola C., and Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22 (1999) 391-397
11. Dong F., Zhang X., Wold L.E., Ren Q., Zhang Z., and Ren J. Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1. Br. J. Pharmacol. 145 (2005) 323-333
12. Fagan S.C., Hess D.C., Hohnadel E.J., Pollock D.M., and Ergul A. Targets for vascular protection after acute ischemic stroke. Stroke 35 (2004) 2220-2225
13. Gorlach A., Brandes R.P., Nguyen K., Amidi M., Dehghani F., and Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ. Res. 87 (2000) 26-32
14. Gupta Y.K., Briyal S., Sharma U., Jagannathan N.R., and Gulati A. Effect of endothelin antagonist (TAK-044) on cerebral ischemic volume, oxidative stress markers and neurobehavioral parameters in the middle cerebral artery occlusion model of stroke in rats. Life Sci. 77 (2005) 15-27
15. Huang Z., Huang P.L., Panahian N., Dalkara T., Fishman M.C., and Moskowitz M.A. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265 (1994) 1883-1885
16. Hunter A.J., Green A.R., and Cross A.J. Animal models of acute ischaemic stroke: can they predict clinically successful neuroprotective drugs?. Trends Pharmacol. Sci. 16 (1995) 123-128
17. Ischiropoulos H., Zhu L., Chen J., Tsai M., Martin J.C., Smith C.D., and Beckman J.S. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch. Biochem. Biophys. 298 (1992) 431-437
18. Lampl Y., Fleminger G., Gilad R., Galron R., Sarova-Pinhas I., and Sokolovsky M. Endothelin in cerebrospinal fluid and plasma of patients in the early stage of ischemic stroke. Stroke 28 (1997) 1951-1955
19. Leung J.W., Ho M.C., Lo A.C., Chung S.S., and Chung S.K. Endothelial cell-specific over-expression of endothelin-1 leads to more severe cerebral damage following transient middle cerebral artery occlusion. J. Cardiovasc. Pharmacol. 44 Suppl. 1 (2004) S293-S300
20. Lin T.N., Nian G.M., Chen S.F., Cheung W.M., Chang C., Lin W.C., and Hsu C.Y. Induction of Tie-1 and Tie-2 receptor protein expression after cerebral ischemia-reperfusion. J. Cereb. Blood Flow Metab. 21 (2001) 690-701
21. Lindsberg P.J., Frerichs K.U., Siren A.L., Hallenbeck J.M., and Nowak Jr. T.S. Heat-shock protein and C-fos expression in focal microvascular brain damage. J. Cereb. Blood Flow Metab. 16 (1996) 82-91
22. Lo A.C., Chen A.Y., Hung V.K., Yaw L.P., Fung M.K., Ho M.C., Tsang M.C., Chung S.S., and Chung S.K. Endothelin-1 overexpression leads to further water accumulation and brain edema after middle cerebral artery occlusion via aquaporin 4 expression in astrocytic end-feet. J. Cereb. Blood Flow Metab. 25 (2005) 998-1011
23. Loo L.S., Ng Y.K., Zhu Y.Z., Lee H.S., and Wong P.T. Cortical expression of endothelin receptor subtypes A and B following middle cerebral artery occlusion in rats. Neuroscience 112 (2002) 993-1000
24. Maczewski M., and Beresewicz A. The role of endothelin, protein kinase C and free radicals in the mechanism of the post-ischemic endothelial dysfunction in guinea-pig hearts. J. Mol. Cell Cardiol. 32 (2000) 297-310
25. Matsuo Y., Mihara S., Ninomiya M., and Fujimoto M. Protective effect of endothelin type A receptor antagonist on brain edema and injury after transient middle cerebral artery occlusion in rats. Stroke 32 (2001) 2143-2148
26. Pryor W.A., and Squadrito G.L. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am. J. Physiol. 268 (1995) L699-L722
27. Rosenberg G.A., Estrada E.Y., and Dencoff J.E. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29 (1998) 2189-2195
28. Traystman R.J., Kirsch J.R., and Koehler R.C. Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J. Appl. Physiol. 71 (1991) 1185-1195
29. Tsang M.C., Lo A.C., Cheung P.T., Chung S.S., and Chung S.K. Perinatal hypoxia-/ischemia-induced endothelin-1 mRNA in astrocyte-like and endothelial cells. NeuroReport 12 (2001) 2265-2270
30. Volpe M., and Cosentino F. Abnormalities of endothelial function in the pathogenesis of stroke: the importance of endothelin. J. Cardiovasc. Pharmacol. 35 (2000) S45-S48
31. Yang Y., Estrada E.Y., Thompson J.F., Liu W., and Rosenberg G.A. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J. Cereb. Blood Flow Metab. 27 (2007) 697-709